These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11209371)

  • 1. Guidelines for administering blood and blood components.
    Gray S; Murphy M
    Nurs Stand; 1999 Dec 15-2000 Jan 4; 14(13-15):36-9. PubMed ID: 11209371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy with cellular blood components].
    Eichler H; Klüter H
    Internist (Berl); 2001 May; 42(5):760-8. PubMed ID: 11400584
    [No Abstract]   [Full Text] [Related]  

  • 3. Implementation of nurse authorisation of blood components.
    Pirie ES; Sinclair C
    Br J Nurs; 2012 Dec 13-2013 Jan 9; 21(22):1328-30, 1332. PubMed ID: 23249800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Time to introduce audit of transfusion treatment. Local transfusion committees should be established in Sweden].
    Schött U; Norda R; Ostlund I; Wikman A
    Lakartidningen; 2010 Dec 15-21; 107(50):3216-20. PubMed ID: 21294336
    [No Abstract]   [Full Text] [Related]  

  • 5. Ten years of transfusion practitioners and better blood transfusion in Scotland.
    Dalrymple K; Watson D
    Nurs Manag (Harrow); 2014 Mar; 20(10):27-30. PubMed ID: 24571162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion of blood components to infants under four months: review and guidelines.
    O'Riordan JM; Fitzgerald J; Smith OP; Bonnar J; Gorman WA;
    Ir Med J; 2007 Jun; 100(6):suppl 1-24 following 496. PubMed ID: 17668683
    [No Abstract]   [Full Text] [Related]  

  • 7. [Scandinavian recommendations for transfusion medicine].
    Eklund J; Jørgensen J; Högman C; Jensson O; Kornstad L
    Nord Med; 1991; 106(11):299-300. PubMed ID: 1945807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A computer-assisted transfusion management system and changed transfusion practices contribute to appropriate management of blood components.
    Ohsaka A; Abe K; Ohsawa T; Miyake N; Sugita S; Tojima I
    Transfusion; 2008 Aug; 48(8):1730-8. PubMed ID: 18482189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model for blood components processing.
    Lowalekar H; Ravichandran N
    Transfusion; 2011 Jul; 51(7 Pt 2):1624-34. PubMed ID: 21736584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adequacy of blood component transfusion according to previously established criteria].
    García Gala JM; Rodríguez Vicente P; Bernal del Castillo T; Martínez Revuelta E; Corte Buelga JR; Rodríguez Luengo J; Vargas Pabón M
    Sangre (Barc); 1996 Feb; 41(1):19-23. PubMed ID: 8779029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical issues in neonatal transfusion practice.
    Strauss RG
    Am J Clin Pathol; 1997 Apr; 107(4 Suppl 1):S57-63. PubMed ID: 9124231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quality of blood products in Mississippi takes another leap forward.
    Jett PL
    J Miss State Med Assoc; 1999 Nov; 40(11):390-1. PubMed ID: 10568090
    [No Abstract]   [Full Text] [Related]  

  • 13. International views on universal leucodepletion: the perspective in NBS, England.
    Wallington T
    Transfus Sci; 1998 Dec; 19(4):347-8. PubMed ID: 10351150
    [No Abstract]   [Full Text] [Related]  

  • 14. Operational and research approaches to universal leucodepletion in Scotland.
    Prowse C
    Transfus Sci; 1998 Dec; 19(4):367-9. PubMed ID: 10351158
    [No Abstract]   [Full Text] [Related]  

  • 15. International views on universal leucodepletion: the perspective in Germany.
    Seitz MD
    Transfus Sci; 1998 Dec; 19(4):359-60. PubMed ID: 10351155
    [No Abstract]   [Full Text] [Related]  

  • 16. [Various methods for good blood supply in Scandinavia].
    Oldinger E
    Nord Med; 1996 Sep; 111(7):212-8. PubMed ID: 8927533
    [No Abstract]   [Full Text] [Related]  

  • 17. International views on universal leucodepletion: the perspective in The Netherlands.
    de Wit HC
    Transfus Sci; 1998 Dec; 19(4):353-4. PubMed ID: 10351153
    [No Abstract]   [Full Text] [Related]  

  • 18. [Developments in blood transfusion].
    Krusius T; Porkka K
    Duodecim; 2004; 120(7):857-9. PubMed ID: 15154306
    [No Abstract]   [Full Text] [Related]  

  • 19. A prospective audit program to determine blood component transfusion appropriateness at a large university hospital: a 5-year experience.
    Jackson GN; Snowden CA; Indrikovs AJ
    Transfus Med Rev; 2008 Apr; 22(2):154-61. PubMed ID: 18353254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.